Stephanie Mgebroff
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Genetics top 5%
- Biomedical Engineering top 10%
- Co-authors
- Ivan BorrelloKimberly NoonanPaolo SerafiniJulie R. ParkMichael C. JensenCatherine LindgrenColleen AnnesleyChristopher Brown
- Topics
- CAR-T cell therapy research (21 papers)Biosimilars and Bioanalytical Methods (3 papers)Nanowire Synthesis and Applications (3 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Stephanie Mgebroff
24 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 1.4k
- Immunology 698
- Molecular Biology 380
- Genetics 359
- Biomedical Engineering 334
Countries citing papers authored by Stephanie Mgebroff
This map shows the geographic impact of Stephanie Mgebroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Mgebroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Mgebroff more than expected).
Fields of papers citing papers by Stephanie Mgebroff
This network shows the impact of papers produced by Stephanie Mgebroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Mgebroff. The network helps show where Stephanie Mgebroff may publish in the future.
Co-authorship network of co-authors of Stephanie Mgebroff
This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Mgebroff. A scholar is included among the top collaborators of Stephanie Mgebroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Mgebroff. Stephanie Mgebroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 14 | |
| 7 | 6 | |
| 8 | 16 | |
| 9 | 10 | |
| 10 | 11 | |
| 11 | 16 | |
| 12 | 23 | |
| 13 | 71 | |
| 14 | 1 | |
| 15 | 75 | |
| 16 | 31 | |
| 17 | 7 | |
| 18 | Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cellsbreakdown → | 557 |
| 19 | 9 | |
| 20 | 1 |
About Stephanie Mgebroff
Stephanie Mgebroff is a scholar working on Oncology, Immunology and Occupational Therapy, having authored 24 papers that have together received 1.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Biosimilars and Bioanalytical Methods (3 papers) and Nanowire Synthesis and Applications (3 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (698 citations) and Genetics (359 citations). Stephanie Mgebroff has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Ivan Borrello, Kimberly Noonan, Paolo Serafini, Julie R. Park, Michael C. Jensen, Catherine Lindgren, Colleen Annesley, Christopher Brown, Olivia Finney and Corinne Summers. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.